RadioSyn
RadioSyn is designing and manufacturing a miniaturized automated radiopharmaceutical synthesis platform. We deliver a shielded, state-of-the-art synthesizer that eliminates traditional production barriers and complexity. Our automated synthesis technology platform addresses critical limitations in conventional diagnostic and therapeutic workflows by standardizing and streamlining radioimmunoconjugate and radiopharmaceutical manufacturing.
Our Platform
Our platform uses disposable microfluidic chips that perform end-to-end chemical and radiochemical reactions. The Radiosyn platform offers reproducible, high-quality radiopharmaceutical production across research and clinical settings, requiring minimal specialized radiochemistry expertise. The device offers cost-effective, on-demand delivery of radiopharmaceuticals, making it ideal for meeting the growing demand for personalized and precision medicine. Our mission is to accelerate scientific discovery and clinical use of radiopharmaceuticals by making their production more accessible, standardized, and scalable.
Our Team
Dr. Sam Sadeghi
CEO, Co-founder
Radiochemistry expert focused on business development and market positioning
Xueyi Wang
CSO, Co-founder
Radiochemistry Lead
Matthew McLennan
Co-op Student, Automotive Engineering
Dr. Ravi Selvaganapathy
CTO, Co-founder
Biomedical engineering expert focused on project management and business development
Shayan Jahangirifard
COO, Co-founder
Engineering Lead
Clara Jonkman
Co-op Student, Chemical and Biomedical Engineering
RadioSyn is hiring!
As we grow, we're looking to expand our technical team with a talented Automation Engineer who can help us build the control systems that drive our novel microfluidic devices. Please send your resume, transcripts and a short cover letter highlighting relevant projects to shayan@radiosyn.com, and visit out LinkedIn posting for more information.
Our Partners
